Drug Trial Radar · NCT00270634
Study of ISA247 (Voclosporin) in De Novo Renal Transplantation
Last checked: Nov 19, 2026Latest source record: Feb 12, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
334
Actual
Start
Jan 2006
Primary completion
Jul 2009
Study completion Jul 2009
Sponsor
- Lead sponsor
- Aurinia Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Dec 28, 2005
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will see if voclosporin is safe and effective in preventing kidney transplant rejection.
Conditions
- Kidney Diseases
Interventions
VoclosporinDrug
voclosporin 0.4, 0.6, 0.8 mg/kg po BID
tacrolimusDrug
tacrolimus 0.05 mg/kg po BID
Primary outcomes
What the sponsor says the trial is designed to measure.
- Biopsy Proven Acute Rejection (BPAR)Time frame: Six months
Locations
45 sites in 2 countries. Site status is shown where the registry gives one.
Isotechnika Investigational Site
Birmingham, Alabama
Isotechnika Investigational Site
Los Angeles, California
Isotechnika Investigational Site
Los Angeles, California
Isotechnika Investigational Site
Los Angeles, California
Isotechnika Investigational Site
Orange, California
Isotechnika Investigational Site
Palo Alto, California
Isotechnika Investigational Site
San Diego, California
Isotechnika Investigational Site
San Francisco, California
Isotechnika Investigational Site
Denver, Colorado
Isotechnika Investigational Site
Gainesville, Florida
Isotechnika Investigational Site
Tampa, Florida
Isotechnika Investigational Site
Chicago, Illinois
Isotechnika Investigational Site
Chicago, Illinois
Isotechnika Investigational Site
Lexington, Kentucky
Isotechnika Investigational Site
New Orleans, Louisiana
Isotechnika Investigational Site
New Orleans, Louisiana
Isotechnika Investigational Site
Baltimore, Maryland
Isotechnika Investigational Site
Boston, Massachusetts
Isotechnika Investigational Site
Ann Arbor, Michigan
Isotechnika Investigational Site
Detroit, Michigan
Isotechnika Investigational Site
Rochester, Minnesota
Isotechnika Investigational Site
Livingston, New Jersey
Isotechnika Investigational Site
Buffalo, New York
Isotechnika Investigational Site
Hawthorne, New York
Isotechnika Investigational Site
New York, New York
Isotechnika Investigational Site
Rochester, New York
Isotechnika Investigational Site
Durham, North Carolina
Isotechnika Investigational Site
Winston-Salem, North Carolina
Isotechnika Investigational Site
Cincinnati, Ohio
Isotechnika Investigational Site
Cincinnati, Ohio
Isotechnika Investigational Site
Portland, Oregon
Isotechnika Investigational Site
Portland, Oregon
Isotechnika Investigational Site
Portland, Oregon
Isotechnika Investigational Site
Philadelphia, Pennsylvania
Isotechnika Investigational Site
Philadelphia, Pennsylvania
Isotechnika Investigational Site
Charleston, South Carolina
Isotechnika Investigational Site
Memphis, Tennessee
Isotechnika Investigational Site
Dallas, Texas
Isotechnika Investigational Site
Houston, Texas
Isotechnika Investigational Site
Richmond, Virginia
Showing 40 of 45 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.